Offer document
Acceptance form – corporate entities
Acceptance form – individuals
26 JULY 2019: AMGEN CONTROLS 98% OF THE SHARES IN NUEVOLUTION AFTER THE END OF THE EXTENDED ACCEPTANCE PERIOD
8 JULY 2019: AMGEN ANNOUNCES THE OUTCOME OF THE RECOMMENDED PUBLIC CASH OFFER TO THE SHAREHOLDERS OF NUEVOLUTION, DECLARES THE OFFER UNCONDITIONAL AND COMPLETES THE OFFER
12 JUNE 2019: AMGEN PUBLISHES OFFER DOCUMENT WITH RESPECT TO THE RECOMMENDED PUBLIC CASH OFFER TO THE SHAREHOLDERS OF NUEVOLUTION
28 MAY 2019: ADDITIONAL IRREVOCABLE UNDERTAKINGS TO ACCEPT AMGEN’S RECOMMENDED PUBLIC CASH OFFER TO THE SHAREHOLDERS OF NUEVOLUTION
21 MAY 2019: AMGEN ANNOUNCES A RECOMMENDED PUBLIC CASH OFFER TO THE SHAREHOLDERS OF NUEVOLUTION
For further information, please contact:
Investors: Arvind Sood, +1 805-447-1060 Media: Trish Hawkins, +1 805-447-5631